Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.48 million versus the consensus estimate of $48.63 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• AES stockholders approve $10.7 billion takeover by GIP and EQT
• FutureFuel director Paul Manheim to retire from board in 2026